REVIEW: Role of Soluble Guanylate Cyclase in the Molecular Mechanism
Underlying the Physiological Effects of Nitric Oxide
I. S. Severina
Institute of Biomedical Chemistry, Russian Academy of Medical Sciences,
Pogodinskaya ul. 10, Moscow, 119832 Russia; fax: (095) 245-0857
Received June 26, 1997
In this review the molecular mechanisms underlying the antihypertensive
and antiaggregatory actions of nitric oxide (NO) are discussed. It has
been shown that these effects are directly connected with the
activation of soluble guanylate cyclase and the accumulation of cyclic
3´,5´-guanosine monophosphate (cGMP). The mechanism of
guanylate cyclase activation by NO is analyzed, especially the role and
biological significance of the nitrosyl--heme complex formed as a
result of interaction of guanylate cyclase heme with NO and the role of
sulfhydryl groups of the enzyme in this process. Using new approaches
for studying the antihypertensive and antiaggregatory actions of nitric
oxide in combination with the newly obtained data on the regulatory
role of guanylate cyclase in the platelet aggregation process, the most
important results were obtained regarding the molecular bases providing
for a directed search for and creation of new effective
antihypertensive and antiaggregatory preparations. In studying the
molecular mechanism for directed activation of soluble guanylate
cyclase by new NO donors, a series of hitherto unknown enzyme
activators generating NO and involved in the regulation of hemostasis
and vascular tone were revealed.
KEY WORDS: guanylate cyclase, nitric oxide, platelet aggregation